FET（EWSR1）-TFCP2 横纹肌肉瘤：这种侵袭性变异型的另一个例子，好发于颌骨。
FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.
机构信息
Division of Oral and Maxillofacial Pathology, School of Dentistry, University of Minnesota, 515 Delaware Street SE #16-116B, Minneapolis, MN, 55455, USA.
Department of Laboratory Medicine and Pathology, Children's Minnesota, Minneapolis, MN, USA.
出版信息
Head Neck Pathol. 2021 Mar;15(1):374-380. doi: 10.1007/s12105-020-01189-1. Epub 2020 Jun 5.
Abstract
An example of a mandibular rhabdomyosarcoma in a 15-year-old male is described featuring EWSR1-TFCP2 fusion with homolateral lymph node metastasis and apparent metastasis to the thoracic vertebra T7. This type of rhabdomyosarcoma has preference for the craniofacial skeleton. Histologically, the tumor was composed of spindle and epithelioid cells characterized by nuclear pleomorphism, cytologic atypia and brisk mitotic activity. Immunohistochemically, it featured diffuse positive nuclear staining MYOD1, only focal staining for myogenin and patchy cytoplasmic staining for desmin. Tumor cells were positive for keratins and nuclear staining for SATB2 was also observed. Interestingly, tumor cells were diffusely positive for calponin. Currently, the patient is under chemotherapy treatment.
摘要
描述了一例发生于 15 岁男性的下颌部横纹肌肉瘤，具有 EWSR1-TFCP2 融合，同侧淋巴结转移，明显转移至胸 7 椎体。这种类型的横纹肌肉瘤偏爱颅面骨骼。组织学上，肿瘤由梭形和上皮样细胞组成，具有核多形性、细胞学异型性和活跃的有丝分裂活性。免疫组化染色，MYOD1 核弥漫阳性，myogenin 仅局灶阳性，desmin 呈灶性胞质阳性。肿瘤细胞角蛋白阳性，SATB2 核染色也可见。有趣的是，肿瘤细胞弥漫性 calponin 阳性。目前，患者正在接受化疗。
相似文献
1
FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.FET（EWSR1）-TFCP2 横纹肌肉瘤：这种侵袭性变异型的另一个例子，好发于颌骨。
Head Neck Pathol. 2021 Mar;15(1):374-380. doi: 10.1007/s12105-020-01189-1. Epub 2020 Jun 5.
2
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.头颈部横纹肌肉瘤伴 TFCP2 融合和 ALK 过表达：11 例临床病理和分子分析。
Histopathology. 2021 Sep;79(3):347-357. doi: 10.1111/his.14323. Epub 2021 May 19.
3
Rhabdomyosarcoma With Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma.下颌骨横纹肌肉瘤伴融合：一种罕见的侵袭性亚型，但易误诊为骨化性纤维瘤。
Int J Surg Pathol. 2024 Jun;32(4):758-766. doi: 10.1177/10668969231189172. Epub 2023 Aug 7.
4
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.骨的梭形细胞横纹肌肉瘤伴 FUS-TFCP2 融合：一种最近描述的横纹肌肉瘤亚型的确认。
Histopathology. 2018 Sep;73(3):514-520. doi: 10.1111/his.13649. Epub 2018 Jun 29.
5
[Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion].[伴有EWSR1/FUS-TFCP2融合的上皮样和梭形细胞横纹肌肉瘤的临床病理研究]
Zhonghua Bing Li Xue Za Zhi. 2024 Jan 8;53(1):58-63. doi: 10.3760/cma.j.cn112151-20230925-00214.
6
Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases.上皮样和梭形细胞横纹肌肉瘤伴 FUS-TFCP2 或 EWSR1-TFCP2 融合：两例报告。
Virchows Arch. 2020 Nov;477(5):725-732. doi: 10.1007/s00428-020-02870-0. Epub 2020 Jun 19.
7
Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.扩大骨内横纹肌肉瘤的谱：2 种不同基因融合与表型的相关性。
Am J Surg Pathol. 2019 May;43(5):695-702. doi: 10.1097/PAS.0000000000001227.
8
Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.梭形细胞横纹肌肉瘤：具有 TFCP2 重排，以及新型 EWSR1::ZBTB41 和 PLOD2::RBM6 基因融合。五例病例研究及文献复习。
Histopathology. 2024 Apr;84(5):776-793. doi: 10.1111/his.15121. Epub 2023 Dec 19.
9
Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.新型 EWSR1::UBP1 融合扩大了梭形细胞横纹肌肉瘤的谱。
Genes Chromosomes Cancer. 2022 Apr;61(4):200-205. doi: 10.1002/gcc.23019. Epub 2021 Dec 14.
10
Mandibular rhabdomyosarcoma with TFCP2 rearrangement and osteogenic differentiation: a case misdiagnosed as fibrous dysplasia or low-grade central osteosarcoma.伴有 TFCP2 重排和骨分化的下颌部横纹肌肉瘤：一例误诊为纤维结构不良或低度中央型骨肉瘤的病例。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Jun;137(6):e143-e149. doi: 10.1016/j.oooo.2023.12.792. Epub 2024 Jan 11.
引用本文的文献
1
Oral Soft Tissue and Jawbone Sarcomas: A Retrospective Clinicopathologic Analysis of 128 Cases from Two Institutions and Comprehensive Literature Review.口腔软组织和颌骨肉瘤：来自两家机构的128例病例回顾性临床病理分析及综合文献综述
Head Neck Pathol. 2025 Jun 17;19(1):74. doi: 10.1007/s12105-025-01811-0.
2
TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.TFCP2融合阳性横纹肌肉瘤：10例报告及文献复习
Cancers (Basel). 2025 Apr 25;17(9):1441. doi: 10.3390/cancers17091441.
3
TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer.TFCP2 作为治疗枢纽：揭示癌症中的分子特征。
Cancer Metastasis Rev. 2024 Sep;43(3):959-975. doi: 10.1007/s10555-024-10175-w. Epub 2024 Mar 7.
4
Pediatric spindle cell/sclerosing rhabdomyosarcoma with fusion: a case report and literature review.伴有 融合的小儿梭形细胞/硬化性横纹肌肉瘤：一例报告及文献复习
Transl Pediatr. 2024 Jan 29;13(1):178-191. doi: 10.21037/tp-23-603. Epub 2024 Jan 24.
5
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.多组学和功能分析用于分类和治疗具有 FUS-TFCP2 或 EWSR1-TFCP2 融合的肉瘤。
Nat Commun. 2024 Jan 2;15(1):51. doi: 10.1038/s41467-023-44360-2.
6
Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review.横纹肌肉瘤伴 TFCP2 重排或 AE1/AE3 和 ALK 的典型共表达：头颈部 3 例新病例报告及文献复习。
Head Neck Pathol. 2023 Jun;17(2):546-561. doi: 10.1007/s12105-022-01507-9. Epub 2022 Nov 14.
7
EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.一名青少年患者中的EWSR1-TFCP2代表了一种极其罕见且侵袭性强的骨内梭形细胞横纹肌肉瘤。
Cold Spring Harb Mol Case Stud. 2022 Jun 29;8(5). doi: 10.1101/mcs.a006209.
8
Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.头颈部横纹肌肉瘤伴 TFCP2 融合和 ALK 过表达：11 例临床病理和分子分析。
Histopathology. 2021 Sep;79(3):347-357. doi: 10.1111/his.14323. Epub 2021 May 19.
本文引用的文献
1
A Feedback Loop Comprising EGF/TGFα Sustains TFCP2-Mediated Breast Cancer Progression.一个由 EGF/TGFα 组成的反馈回路维持 TFCP2 介导的乳腺癌进展。
Cancer Res. 2020 Jun 1;80(11):2217-2229. doi: 10.1158/0008-5472.CAN-19-2908. Epub 2020 Mar 19.
2
SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.SRF-FOXO1 和 SRF-NCOA1 融合基因划定了具有显著特征的分化良好型横纹肌肉瘤亚群。
Am J Surg Pathol. 2020 May;44(5):607-616. doi: 10.1097/PAS.0000000000001464.
3
Epithelioid rhabdomyosarcoma: Report of the first case in the jaw.上皮样横纹肌肉瘤：颌骨首例报告。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Nov;130(5):e308-e315. doi: 10.1016/j.oooo.2020.01.004. Epub 2020 Mar 12.
4
Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor.炎性平滑肌肉瘤常表达平滑肌和骨骼肌标志物，支持原始肌源性表型：9 例报告并建议重新分类为低度炎性肌源性肿瘤。
Virchows Arch. 2020 Aug;477(2):219-230. doi: 10.1007/s00428-020-02774-z. Epub 2020 Feb 20.
5
The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript.放射治疗与ALK抑制剂联合使用对治疗伴有FUS-TFCP2融合转录本的骨内横纹肌肉瘤有效。
Pediatr Blood Cancer. 2020 May;67(5):e28185. doi: 10.1002/pbc.28185. Epub 2020 Jan 21.
6
Soft Tissue Special Issue: Skeletal Muscle Tumors: A Clinicopathological Review.软组织专题：骨骼肌肿瘤：临床病理综述
Head Neck Pathol. 2020 Mar;14(1):12-20. doi: 10.1007/s12105-019-01113-2. Epub 2020 Jan 16.
7
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.一小部分上皮样和梭形细胞横纹肌肉瘤与 TFCP2 融合和常见的 ALK 上调有关。
Mod Pathol. 2020 Mar;33(3):404-419. doi: 10.1038/s41379-019-0323-8. Epub 2019 Aug 5.
8
Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.扩大骨内横纹肌肉瘤的谱：2 种不同基因融合与表型的相关性。
Am J Surg Pathol. 2019 May;43(5):695-702. doi: 10.1097/PAS.0000000000001227.
9
Zfp423 Regulates Skeletal Muscle Regeneration and Proliferation.Zfp423 调节骨骼肌再生和增殖。
Mol Cell Biol. 2019 Apr 2;39(8). doi: 10.1128/MCB.00447-18. Print 2019 Apr 15.
10
Mutant p53 in cancer therapy-the barrier or the path.癌症治疗中的突变型 p53：障碍还是途径。
J Mol Cell Biol. 2019 Apr 1;11(4):293-305. doi: 10.1093/jmcb/mjy072.
Zotero 插件